THERAVANCE BIOPHARMA INC's ticker is and the CUSIP is 88339KAA0.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2021 | $1,414,000 | -93.3% | 1,500,000 | -92.7% | 0.01% | -93.8% |
Q1 2021 | $20,968,000 | -8.1% | 20,600,000 | -14.5% | 0.18% | +5.4% |
Q4 2020 | $22,817,000 | +7.2% | 24,100,000 | 0.0% | 0.17% | -11.1% |
Q3 2020 | $21,294,000 | -9.3% | 24,100,000 | 0.0% | 0.19% | -19.9% |
Q2 2020 | $23,476,000 | -1.0% | 24,100,000 | 0.0% | 0.24% | -31.4% |
Q1 2020 | $23,717,000 | -5.1% | 24,100,000 | 0.0% | 0.34% | +18.6% |
Q4 2019 | $24,989,000 | +11.6% | 24,100,000 | 0.0% | 0.29% | +2.1% |
Q3 2019 | $22,397,000 | +7.0% | 24,100,000 | 0.0% | 0.28% | +4.0% |
Q2 2019 | $20,926,000 | -10.8% | 24,100,000 | 0.0% | 0.27% | -14.7% |
Q1 2019 | $23,451,000 | -5.3% | 24,100,000 | 0.0% | 0.32% | +7.7% |
Q4 2018 | $24,760,000 | -13.3% | 24,100,000 | 0.0% | 0.30% | -10.5% |
Q3 2018 | $28,543,000 | +20.0% | 24,100,000 | 0.0% | 0.33% | +7.8% |
Q2 2018 | $23,789,000 | -2.8% | 24,100,000 | 0.0% | 0.31% | -2.8% |
Q1 2018 | $24,481,000 | -7.4% | 24,100,000 | 0.0% | 0.32% | +18.7% |
Q4 2017 | $26,424,000 | -10.2% | 24,100,000 | +0.3% | 0.27% | -18.1% |
Q3 2017 | $29,431,000 | -9.3% | 24,020,000 | 0.0% | 0.33% | -20.9% |
Q2 2017 | $32,436,000 | +21.7% | 24,020,000 | +14.4% | 0.41% | -0.5% |
Q1 2017 | $26,657,000 | +10.2% | 21,000,000 | 0.0% | 0.41% | +32.7% |
Q4 2016 | $24,181,000 | – | 21,000,000 | – | 0.31% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Context Capital Management, LLC | 25,388 | $23,544,000 | 2.40% |
HIGHBRIDGE CAPITAL MANAGEMENT LLC | 49,675,000 | $46,013,000 | 1.22% |
DeepCurrents Investment Group LLC | 33,824,000 | $31,165,000 | 0.93% |
Aequim Alternative Investments LP | 13,920,000 | $12,909,000 | 0.50% |
Maven Securities LTD | 14,280,000 | $14,280,000 | 0.46% |
Saltoro Capital, LP | 1,350,000 | $1,252,000 | 0.44% |
Baupost Group | 30,000,000 | $27,640,000 | 0.25% |
TENOR CAPITAL MANAGEMENT Co., L.P. | 5,500,000 | $5,182,000 | 0.12% |
ZAZOVE ASSOCIATES LLC | 1,250,000 | $1,163,000 | 0.10% |
HBK INVESTMENTS L P | 22,500,000 | $20,832,000 | 0.08% |